Synthesis Srl
- Company typePrivate
- Founded-
- Headquarters—
- Headcount11–50
- GTM typeB2B
- OfferingServices
Synthesis Srl firmographics
Firmographics- Name
- Synthesis Srl
- Website
- https://synthesis-srl.it
- Company type
- Private
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Synthesis Srl industry classification
Industry- Product category
- Unknown
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG)
- akta.pro secondary industries
- GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)
Keywords
Synthesis Srl business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel
Synthesis Srl product offering
Product offeringCore offering
No description of core offerings is available in the source content. The only verifiable facts about Synthesis Srl are its Italian Srl legal form, 2020 founding date, 23-employee headcount, and Milan-based headquarters. The company's website returned only a security verification/loading page.
Differentiator
Problem solved
Functional benefit
Synthesis Srl technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Synthesis Srl competitors and assessment
Company assessmentDirect peers
- Toronto Research Chemicals: Specialty manufacturer of reference standards, impurities, and research chemicals — directly comparable if Synthesis Srl is positioned in impurity / reference-standard synthesis and characterization.
- Procos S.p.A. Italian CDMO focused on small-molecule API development and manufacturing, including custom synthesis and process R&D — a direct competitor for synthesis contracts from European pharma customers.
- Olon S.p.A. Italian API manufacturer with a strong position in generic and contract small-molecule synthesis, including HPAPI and fermentation. Comparable as a domestic Italian peer in the same chemistry/synthesis services category.
- Chemo S.A. (Insud Pharma): Spanish-headquartered pharma group with significant Italian operations (Chemo Italy) covering API synthesis, CDMO and finished dosage forms — comparable scale and service offering for small-molecule synthesis work.
- Fabbrica Italiana Sintetici (FIS): Italian CDMO headquartered near Vicenza specializing in API synthesis, GMP manufacturing and process development for small molecules — a directly comparable Italian synthesis services operator with similar offerings to the inferred profile of Synthesis Srl.
Broad incumbents
- Recipharm: Large European CDMO offering a broad portfolio including small-molecule API synthesis alongside fill-finish and biologics — represents the incumbent competitive backdrop for small Italian synthesis specialists.
- Sigma-Aldrich (Merck KGaA): Global life-science catalog supplier with an extensive reference-standard and analytical chemicals portfolio — represents the dominant incumbent that any small Italian synthesis entrant must displace or differentiate against.
- Siegfried Holding AG: Swiss-listed CDMO with deep capabilities in small-molecule API synthesis and process industrialization. A larger, established counterpart competing for similar European pharma development contracts.
- LGC Standards: Major global supplier of reference standards, CRMs and impurity standards used by pharma QC labs — directly relevant competitor if Synthesis Srl serves the impurity / reference-standard niche.
- Eurofins CDMO: Eurofins network offers contract analytical and small-molecule synthesis/CMC services across Europe; a large incumbent competitor relevant to Synthesis Srl's likely service offering.
Market position
Strengths3 records
Weaknesses3 records
Key risks4 records
Key highlights3 records
Customer concentration
Synthesis Srl social profiles
Digital presenceSynthesis Srl financial estimates
Financial estimateRevenue estimate
Valuation estimate
Synthesis Srl leadership team
Management profileNumber of profiles
Synthesis Srl funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Synthesis Srl M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Synthesis Srl
What does Synthesis Srl do?
No description of core offerings is available in the source content. The only verifiable facts about Synthesis Srl are its Italian Srl legal form, 2020 founding date, 23-employee headcount, and Milan-based headquarters. The company's website returned only a security verification/loading page.
When was Synthesis Srl founded?
Synthesis Srl was founded in -1. It employs 11 to 50 people.
Who are Synthesis Srl's main competitors?
Direct peers on record are Toronto Research Chemicals, Procos S.p.A., Olon S.p.A., Chemo S.A. (Insud Pharma) and Fabbrica Italiana Sintetici (FIS). Broad incumbents are Recipharm, Sigma-Aldrich (Merck KGaA), Siegfried Holding AG, LGC Standards and Eurofins CDMO.
Does Synthesis Srl have an API?
No public API is recorded for Synthesis Srl.
What industry is Synthesis Srl in?
Synthesis Srl's product category is Unknown. Its primary akta.pro industry code is HLAGAHAG, Impurity / Reference Standard Synthesis & Characterization, with a secondary code of HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ). Its NAICS code is 541714 and its SIC code is 8731.